During the symposium the language spoken is English.
13:00 - 13:10 uur - Introduction
by the chairs Joost Bijlsma, internist-nefroloog Stichting Dianet en Henrieke Struijk, internist-nefroloog in training Amsterdam UMC location AMC
13:10 - 13:55 uur - PD: landmarks and historical developments
professor dr. Bengt Lindholm, Head of the Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden
In the 1960s and 1970s peritoneal dialysis was recognized as a valuable addition to the range of renal replacement therapies available. The introduction of CAPD in the late 1970s was the beginning of PD as a major home therapy. The challenges about safety and efficacy, peritonitis and biocompatibility will be reviewed and landmarks from the 1970s onward will be highlighted.
14:00 - 14:45 uur - PD: actual and future developments
professor dr. Martin Wilkie, Consultant renal physician and honorary professor at Sheffield Teaching Hospitals NHS Foundation Trust, UK and Editor in Chief of Peritoneal Dialysis International
Peritoneal dialysis has been recognized as standard renal replacement therapy and not merely as an alternative for hemodialysis. Many improvements have been made and major concerns about safety and efficacy have been solved. However, at present incident PD usage in end stage renal disease is only 30% at best rates. With the growing need for selfcare modalities in our healthcare system we will need innovations to ensure the future of PD. The present state and future perspectives will be reviewed.
14:45 - 15:15 uur - Teabreak
15:15 - 15:45 uur - EPS in the Netherlands: past and present
dr. Michiel Betjes, internist-nefroloog Erasmus Medisch Centrum Rotterdam
Encapsulated peritoneal sclerosis has been a feared complication of peritoneal dialysis. It can have devastating consequences beyond merely PD technique failure and even years after stopping PD. Pathophysiology, associations, causality and outcomes will be reviewed.
15:45 - 16:15 uur - PD in the treatment of heart failure
dr. Stijn Konings, internist-nefroloog Catharina Ziekenhuis Eindhoven and Elkerliek Ziekenhuis Deurne
In heart failure often the combination of fluid overload, diuretic therapy and forward failure poses patients at risk for acute and chronic kidney failure. Peritoneal dialysis has been used as a treatment strategy for fluid overload irrespective of kidney function. The rationale, indications and results of PD in heart failure will be reviewed.
16:15 - 16:55 uur - Lessons learned from peritoneal transport research during 30 years
dr. Dick Struijk, internist-nefroloog Stichting Dianet and Amsterdam UMC location AMC
Peritoneal transport rates determine PD efficacy but very widely among patients. A tool for the assessment of peritoneal permeability characteristics in PD patients is the standard peritoneal equilibration test, the PET test. Such tests use the movement of solutes and water across the peritoneal membrane and have important implications for individual patient management. The lessons learned from peritoneal transport research, which has been the focus of interest in our centre for 30 years, will be reviewed and put into future perspectives.
16:55 - 17:00 uur - Closure
drs. Wendela Hingst, voorzitter Raad van Bestuur Stichting Dianet
17:00 - 19:00 uur - Reception
Symposium Peritoneal dialysis: past, present and futureRegistratiewebsite voor Symposium Peritoneal dialysis: past, present and future
Symposium Peritoneal dialysis: past, present and futureSymposium Peritoneal dialysis: past, present and future0.00EUR
Amsterdam UMC locatie AMCAmsterdam UMC locatie AMCMeibergdreef 9 1105 AZ Amsterdam Zuidoost Nederland